Suchergebnisse - (Person:"Barreiro, Pablo")

PubPharm (452)

141

Pharmacogenetics of antiretroviral therapy

enthalten in: Expert opinion on drug metabolism & toxicology | 2014

von Barreiro, P. | Fernández-Montero, J. | de Mendoza, C. | +2

142

Management and treatment of chronic hepatitis B in HIV-positive patients

enthalten in: Annals of medicine | 2014

von Soriano, V. | de Mendoza, C. | Fernández-Montero, J. | +2

143

Pharmacogenetics of antiretroviral therapy

enthalten in: Expert opinion on drug metabolism & toxicology | 2014

von Barreiro, P. | Fernández-Montero, J. | de Mendoza, C. | +2

144

Management and treatment of chronic hepatitis B in HIV-positive patients

enthalten in: Annals of medicine | 2014

von Soriano, V. | de Mendoza, C. | Fernández-Montero, J. | +2

145

Hepatitis E : an emerging viral disease

enthalten in: Medicina clinica | 2014

von Soriano, V. | Barreiro, P.

146

Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy

enthalten in: AIDS (London, England) | 2014

von Vispo, E. | Barreiro, P. | Plaza, Z. | +7

CommentIn: AIDS. 2014 Sep 10;28(14):2169-70. - PMID 25265084

147

Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2014

von Fernández-Montero, J. | Vispo, E. | Barreiro, P. | +4

148

Dolutegravir, abacavir and lamivudine as HIV therapy

enthalten in: Expert opinion on pharmacotherapy | 2014

von Fernandez-Montero, J. | Barreiro, P. | Labarga, P. | +2

149

Towards hepatitis C eradication from the HIV-infected population

enthalten in: Antiviral research | 2014

von Barreiro, P. | Fernandez-Montero, J. | de Mendoza, C. | +2

150

Towards hepatitis C eradication from the HIV-infected population

enthalten in: Antiviral research | 2014

von Barreiro, P. | Fernandez-Montero, J. | de Mendoza, C. | +2